Optimal environmental drivers of high-mountains forest: Polylepis tarapacana cover evaluation in their southernmost distribution range of the Andes

The Andes Mountains are considered a global biodiversity hotspot, where Polylepis forests are one of the most threatened forests in the area. We evaluate the P. tarapacana forest's distribution and cover and relate this pattern with topographic, climatic and geographic environmental factors at the landscape level. Along 93 plots, forest structure data was conducted according to their homogeneity, accessibility, and size (patches up to > 1 ha each). Hexagon binning processes were used to estimate the forest cover, as the proportion of hexagon area covered by forests, and one-way ANOVAs were conducted to evaluate its variation according to the environmental factors. Our results show that P. tarapacana forests are widely distributed, occupying a forest area of 8519.8 ha among 2462 forest patches and an average of 6.7% of forest cover (1296 hexagons - 129600 ha). According to the findings, the entire forest distribution encompasses a wide range of environmental conditions. We identify that the slopes and elevations were the main environmental drivers that shaped P. tarapacana distribution and cover. Variations in forest area and cover indicate a strong preference for north and east-facing slopes (18 and 24°) and intermediate elevations (4400 - 4500 m a.s.l), with a life zone of Tropical subalpine dry scrub accounting for 62.1%. Our research shows that remote sensing mapping and geographic information systems are effective methods for identifying habitat variables linked to threatened forest cover and evidence of forest vulnerability in the face of continuous global change.Fil: Lopez, Victoria Lien. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Agrarias y Forestales; ArgentinaFil: Huertas Herrera, Alejandro. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Rosas, Yamina Micaela. Universidad de Copenhagen; Dinamarca. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Cellini, Juan Manuel. Universidad Nacional de La Plata. Facultad de Ciencias Agrarias y Forestales; Argentin

Vulnerabilidad territorial ante la expansión urbana

En México según el INEGI para el 2010 la población urbana fue del 77.8%, lo que significa que un porcentaje importante de la población vive en localidades mayores a los 2500 habitantes. Las cuales tienen sus propios ritmos de crecimiento, funciones, especialización, cambios de usos del suelo y problemáticas específicas. Las ciudades principales se han expandido, en las últimas décadas, con escasa acción planificadora y bajos resultados en el ordenamiento territorial. Ello ha configurado crecimientos físicos dispersos y fragmentados con importantes efectos ambientales. En México, la dispersión urbana genera ocupación del territorio en riesgos, situaciones de vulnerabilidad con inexistencia de acciones públicas, porque se encuentra en pendientes abruptas, lugares que se inundan, en áreas naturales protegidas, entre otras formas, genera tejido construido en áreas no óptimas para el desarrollo urbano, todo ello impacta negativamente al medio ambiente y la calidad de vida de la población. El crecimiento urbano continuará porque en las ciudades se genera la riqueza del país, en ellas se encuentran las oportunidades y soluciones. La urbanización es el modelo para conseguir el desarrollo de la sociedad. En dicho desarrollo se aspira el crecimiento sustentable y armonioso con el ambiente. Se espera cambios regulatorios para revertir los efectos negativos generados durante décadas con la expansión urbana consumidora de recursos naturales, energía y recursos financieros. En este marco problemático se integra el libro “Vulnerabilidad territorial ante la expansión urbana”, es producto de las actividades científicas –foro y congreso realizados en 2015- de la Red internacional de territorios, sustentabilidad y gobernanza en México y Polonia (RETESYG) de la Facultad de Geografía, Facultad de Planeación Urbana y Regional de la Universidad Autónoma del Estado de México (UAEM), así como de la Facultad de Geografía y Estudios Regionales de la Universidad de Varsovia (UV) y la Facultad de Geografía y Biología de la Universidad Pedagógica “Comisión de Educación Nacional” de Cracovia. El libro tiene una visión integral de la vulnerabilidad territorial ante la expansión urbana, considera los enfoques de la geografía, de la planeación y del ordenamiento territorial para abordar las problemáticas ambiental y social. Presenta una visión amplia y de síntesis sobre vulnerabilidad del territorio y de las ciudades, en él se integran los saberes de la Geografía y de la Planeación Territorial. Destaca la necesidad de controlar el crecimiento anárquico y desordenado, las desigualdades sociales, los riesgos, los problemas ambientales, la falta de bases de datos geoespaciales dinámicas, entre otros. Los resultados de las investigaciones apuntan hacia el desarrollo territorial sustentable. El libro se conforma de dos partes, la primera presenta aspectos teóricos conceptuales y metodológicos de la vulnerabilidad territorial, estructural, física, ambiental y socioeconómica, los riesgos geomorfológicos, la sustentabilidad y manejo de recursos naturales, áreas naturales protegidas, metodologías para la evaluación de los impactos de la expansión metropolitana y gobernanza territorial. La segunda parte, desarrolla estudios de caso, a distintas escalas: desde huertos familiares, subcuentas, ciudad, municipio, zonas metropolitanas, megalópolis, regiones y país. En cada capítulo del libro se presenta bibliografía extensa, diversificada y actualizada que aportan al lector sobre el estado del arte de la vulnerabilidad territorial

Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

Objectives The course and long-term outcome of pure membranous lupus nephritis (MLN) are little understood. The aims of this study are to evaluate the clinical features, course, outcome and prognostic indicators in pure MLN and to determine the impact of ethnicity and the type of health insurance on the course and prognosis of pure MLN. Methods We conducted a retrospective review of medical records of 150 patients with pure MLN from Spain and the USA. Results Mean age was 34.2±12.5 and 80% were women. Sixty-eight percent of patients had nephrotic syndrome at diagnosis. The average serum creatinine was 0.98±0.78mg/dl. Six percent of patients died and 5.3% developed end-stage renal disease (ESRD). ESRD was predicted by male sex, hypertension, dyslipidemia, high basal 24h-proteinuria, high basal serum creatinine and a low basal creatinine clearance. Age, cardiac insufficiency, peripheral artheriopathy, hemodialysis and not having received mycophenolate mofetil or antimalarials for MLN predicted death. Conclusions Pure MLN frequently presents with nephrotic syndrome, high proteinuria and normal serum creatinine. Its prognosis is favourable in maintaining renal function although proteinuria usually persists over time. Baseline cardiovascular disease and not having a health insurance are related with poor prognosis

Nothing at Stake in Knowledge

Many philosophers hold that stakes affect ordinary knowledge ascriptions. Here’s a version of a pair of cases aimed at supporting this: Bob and his wife are driving home on Friday and considering whether to stop at the bank to deposit a check. The lines at the bank are very long and so Bob considers coming back on Saturday. In the low stakes version, nothing of importance hinges on whether the check is deposited; in the high stakes version, it is very important that the check be deposited. Bob’s wife asks whether the bank will be open on Saturday. Bob says he drove past the bank last Saturday, and it was open. However, his wife points out that banks sometimes change their hours. Bob says “I know the bank will be open tomorrow”. In the low stakes case, many philosophers maintain that Bob does indeed know that the bank will be open; in the high stakes case, these philosophers maintain that Bob is ignorant – his statement that he knows the bank will be open tomorrow is false. These philosophers also maintain that this pattern of judgments is what we would expect from competent speakers confronted with this and similar cases (e.g., Cohen, 1999, 2013; DeRose, 1992, 2009; Fantl and McGrath, 2002; Nagel, 2008; Rysiew, 2001; Stanley, 2005). Though many philosophers agree that stakes play a role in ordinary knowledge ascriptions, there is disagreement about what explains this. One view, epistemic contextualism, holds that “to know” is a context sensitive verb and that the truth conditions for knowledge ascriptions can vary across conversational contexts (e.g., DeRose, 2009). For instance, Bob’s statement “I know the bank will be open tomorrow” can be true in low stakes contexts and false in high stakes contexts. Another view, interest-relative invariantism, denies that “to know” is a context sensitive verb and that the truth conditions for knowledge ascriptions vary according to conversational contexts. Instead, cases like the Bank cases show that practical factors—i.e., stakes—play a distinctive role in determining whether the knowledge relation obtains (e.g., Stanley, 2005). Yet another alternative, which we’ll call classical invariantism, denies that “to know” is a context sensitive verb and that practical factors, such as stakes, play a direct role in determining whether the knowledge relation obtains. Instead, stakes affect knowledge ascriptions only by affecting our assessment of factors that have traditionally been taken to constitute or be necessary for knowledge, such as e.g., belief, quality of evidence, etc. (e.g., Bach, 2005; Weatherson, 2005; Ganson, 2007; Nagel, 2008). If this is right, then the role of stakes in knowledge ascriptions fails to motivate such surprising views as epistemic contextualism or interest-relative invariantism. Naturally, epistemic contextualists and interest-relative invariantists deny this, claiming that even when the factors that have traditionally been taken to constitute or be necessary for knowledge are held fixed, stakes continue to play a role in ordinary knowledge ascriptions (e.g., DeRose, 2009; Lawlor, 2013). So we see a dispute over what best explains the role of stakes in ordinary knowledge ascriptions. It is thus extremely surprising that a wide range of empirical evidence suggests that ordinary knowledge ascriptions fail to display any sensitivity to stakes (e.g., Buckwalter, 2010; Buckwalter and Schaffer, 2015; Feltz and Zarpentine, 2010; May, Sinnott-Armstrong, Hull, and Zimmerman, 2010; Turri, forthcoming; though see e.g., Pinillos, 2012; Pinillos and Simpson, 2014; Sripada and Stanley, 2012). If stakes really do not play any role in ordinary knowledge ascriptions, one of the main motivations for epistemic contextualism and interest relative invariantism would be undermined. Perhaps these different explanations of the role of stakes in ordinary knowledge ascription are born out of nothing more than a myth (Schaffer and Knobe, 2009). If so, classical invariantism about knowledge might be best supported—not because it provides the best explanation of the role of stakes in ordinary knowledge ascriptions, but rather because the failure of stakes to play a role in ordinary knowledge ascription would undercut an important motivation for its two competitors, epistemic contextualism and interest-relative invariantism. These radical alternatives to classical invariantism, lacking evidence in support of one of their important motivations, should perhaps then fall. Classical invariantism would stand. In the remainder of this article, we’ll disarm an important motivation for epistemic contextualism and interest-relative invariantism. We’ll accomplish this by presenting a stringent test of whether there is a stakes effect on ordinary knowledge ascription. Having shown that, even on a stringent way of testing, stakes fail to impact ordinary knowledge ascription, we will conclude that we should take another look at classical invariantism. Here is how we will proceed. Section 1 lays out some limitations of previous research on stakes. Section 2 presents our study and concludes that there is little evidence for a substantial stakes effect. Section 3 responds to objections. The conclusion clears the way for classical invariantism

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Background: Approximately 450 000 children are born with familial hypercholesterolaemia worldwide every year, yet only 2·1% of adults with familial hypercholesterolaemia were diagnosed before age 18 years via current diagnostic approaches, which are derived from observations in adults. We aimed to characterise children and adolescents with heterozygous familial hypercholesterolaemia (HeFH) and understand current approaches to the identification and management of familial hypercholesterolaemia to inform future public health strategies. Methods: For this cross-sectional study, we assessed children and adolescents younger than 18 years with a clinical or genetic diagnosis of HeFH at the time of entry into the Familial Hypercholesterolaemia Studies Collaboration (FHSC) registry between Oct 1, 2015, and Jan 31, 2021. Data in the registry were collected from 55 regional or national registries in 48 countries. Diagnoses relying on self-reported history of familial hypercholesterolaemia and suspected secondary hypercholesterolaemia were excluded from the registry; people with untreated LDL cholesterol (LDL-C) of at least 13·0 mmol/L were excluded from this study. Data were assessed overall and by WHO region, World Bank country income status, age, diagnostic criteria, and index-case status. The main outcome of this study was to assess current identification and management of children and adolescents with familial hypercholesterolaemia. Findings: Of 63 093 individuals in the FHSC registry, 11 848 (18·8%) were children or adolescents younger than 18 years with HeFH and were included in this study; 5756 (50·2%) of 11 476 included individuals were female and 5720 (49·8%) were male. Sex data were missing for 372 (3·1%) of 11 848 individuals. Median age at registry entry was 9·6 years (IQR 5·8-13·2). 10 099 (89·9%) of 11 235 included individuals had a final genetically confirmed diagnosis of familial hypercholesterolaemia and 1136 (10·1%) had a clinical diagnosis. Genetically confirmed diagnosis data or clinical diagnosis data were missing for 613 (5·2%) of 11 848 individuals. Genetic diagnosis was more common in children and adolescents from high-income countries (9427 [92·4%] of 10 202) than in children and adolescents from non-high-income countries (199 [48·0%] of 415). 3414 (31·6%) of 10 804 children or adolescents were index cases. Familial-hypercholesterolaemia-related physical signs, cardiovascular risk factors, and cardiovascular disease were uncommon, but were more common in non-high-income countries. 7557 (72·4%) of 10 428 included children or adolescents were not taking lipid-lowering medication (LLM) and had a median LDL-C of 5·00 mmol/L (IQR 4·05-6·08). Compared with genetic diagnosis, the use of unadapted clinical criteria intended for use in adults and reliant on more extreme phenotypes could result in 50-75% of children and adolescents with familial hypercholesterolaemia not being identified. Interpretation: Clinical characteristics observed in adults with familial hypercholesterolaemia are uncommon in children and adolescents with familial hypercholesterolaemia, hence detection in this age group relies on measurement of LDL-C and genetic confirmation. Where genetic testing is unavailable, increased availability and use of LDL-C measurements in the first few years of life could help reduce the current gap between prevalence and detection, enabling increased use of combination LLM to reach recommended LDL-C targets early in life

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to &lt;90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], &gt;300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of &lt;15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P&lt;0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P&lt;0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years

Measurement of t(t)over-bar normalised multi-differential cross sections in pp collisions at root s=13 TeV, and simultaneous determination of the strong coupling strength, top quark pole mass, and parton distribution functions

Peer reviewe

An embedding technique to determine ττ backgrounds in proton-proton collision data

An embedding technique is presented to estimate standard model tau tau backgrounds from data with minimal simulation input. In the data, the muons are removed from reconstructed mu mu events and replaced with simulated tau leptons with the same kinematic properties. In this way, a set of hybrid events is obtained that does not rely on simulation except for the decay of the tau leptons. The challenges in describing the underlying event or the production of associated jets in the simulation are avoided. The technique described in this paper was developed for CMS. Its validation and the inherent uncertainties are also discussed. The demonstration of the performance of the technique is based on a sample of proton-proton collisions collected by CMS in 2017 at root s = 13 TeV corresponding to an integrated luminosity of 41.5 fb(-1).Peer reviewe